Cipla, leading drug maker registered a rise in share price on Thursday after it announced that Medpro Pharmaceutica, a subsidiary of the Cipla Medpro has entered into collaboration with Teva Pharmaceuticals, an affiliate of Teva Pharmaceutical Industries. The collaboration is restricted to the territory of South Africa.

The collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva's broad pharmaceutical product portfolio in South Africa.

Shares of the company are trading at Rs 597.05, up Rs 11.75, or 2.01% at the Bombay Stock Exchange (BSE) on Thursday at 10:27 a.m.

The scrip has touched an intra-day high of Rs 604.85 and low of Rs 587.65. The total volume of shares traded at the BSE is 96,396.